METTL3 ‐mediated ALDH m 6 A methylation regulates the malignant behavior of BMI1 + HNSCC stem cells
Oral Diseases · 2024
DOI: 10.1111/odi.14609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Zhi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Ch…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Polycomb Repressive Complex 1, Squamous Cell Carcinoma of Head and Neck, Methyltransferases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China, 2022 Guangzhou Science and Technology Plan Basic and Applied Basic Research Project.
Abstract (Originalsprache)
Objectives
To reveal the effect and mechanism of methyltransferase‐like 3 (METTL3) on cancer stem cells (CSCs) of head and neck squamous cell carcinoma (HNSCC). Materials and Methods First, we analyzed 14‐HNSCC‐patients’ scRNA‐seq dataset and TCGA dataset of HNSCC. Then, Mettl3 knockout or overexpression mice models were studied via tracing and staining technologies. In addition, we took flow cytometry sorting and sphere formation assays to observe tumorigenicity and used cell transfection and western blotting to verify target protein expression levels. Furthermore, methylated RNA immunoprecipitation sequencing (MeRIP‐seq) and MeRIP‐quantitative real‐time PCR (MeRIP‐qPCR) were taken to identify the mechanism of Mettl3 regulating Bmi1 + CSCs in HNSCC.
Results
Due to SOX4 transcriptional regulation, METTL3 regulated the malignant behavior of BMI1 + HNSCC stem cells through cell division pathway. The progression and malignancy of HNSCC were decreased after Mettl3 knocked‐out, while increased after Mettl3 knocked‐in in Bmi1 + CSCs in vivo. Knockdown of Mettl3 inhibited stemness properties of CSCs in vitro. Mechanically, Mettl3 mediated the m 6 A modification of ALDH1A3 and ALDH7A1 mRNA in Bmi1 + HNSCC CSCs.
Conclusion
Regulated by SOX4, METTL3‐mediated ALDH m 6 A methylation regulates the malignant behavior of BMI1 + HNSCC CSCs through cell division pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Hospital of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China.
- Department of Stomatology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
ORCID-Profile: Zhi Chen, Qianting He
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province, China
- 2022 Guangzhou Science and Technology Plan Basic and Applied Basic Research Project
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Chen, Z., Chen, J., Xu, X., Li, Q., Zhang, C., Li, S., Liu, L., Cao, C., Chen, D., & He, Q. (2024). METTL3 ‐mediated ALDH m 6 A methylation regulates the malignant behavior of BMI1 + HNSCC stem cells. Oral Diseases. https://doi.org/10.1111/odi.14609
Vancouver
Chen Z, Chen J, Xu X, Li Q, Zhang C, Li S, et al. METTL3 ‐mediated ALDH m 6 A methylation regulates the malignant behavior of BMI1 + HNSCC stem cells. Oral Diseases. 2024. doi:10.1111/odi.14609
BibTeX
@article{Chen2024,
author = {Chen, Zhi and Chen, Jie and Xu, Xiaohong and Li, Qiuli and Zhang, Caihua and Li, Shuai and Liu, Lianlian and Cao, Congyuan and Chen, Demeng and He, Qianting},
title = {METTL3 ‐mediated ALDH m 6 A methylation regulates the malignant behavior of BMI1 + HNSCC stem cells},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14609}
}
EUVIMED